Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

Cited by (480)

Items 401–480 of 480

1. Altered drug metabolism in critically ill children: a significant source of adverse effects?.
   S. Poloyac · 2012 · Pediatric Critical Care Medicine
2. Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats
   A. Maza, A. Gascón, R. Hernandez, M. Solinís, M. B. Calvo, J. Pedraz · 2010 · European journal of drug metabolism and pharmacokinetics
3. Pharmacokinetics of Dexamethasone in Tuberculous Meningitis
   Jose M. Calderin, J. E. Reséndiz-Galván, N. Abdelgawad, A. Davis, C. Stek, L. Wiesner, G. Meintjes, R. Wilkinson, P. Denti, Sean Wasserman · 2025 · Clinical Infectious Diseases
4. Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110).
   Ramakrishna Rachumallu, J. Cheong, Gauri Deshmukh, Bin Ma, Danielle Sharpnack, Liling Liu, S. Ubhayakar, Elisia Villemure, Elizabeth S. Levy, Joachim Rudolph et al. · 2025 · Drug Metabolism And Disposition
5. The influence of individual gastrointestinal physiology parameters on prediction of regional drug absorption
   Harshad Jadhav, Patrick Augustijns, Christer Tannergren · 2025 · International Journal of Pharmaceutics
6. Selection of an Optimal Metabolic Model for Accurately Predicting the Hepatic Clearance of Albumin-Binding-Sensitive Drugs
   Ren-Jong Liang, Shu-Hao Hsu, Hsueh-Tien Chen, Wan-Han Chen, Han-Yu Fu, Hsin-Ying Chen, Hong-Jaan Wang, Sung‐Ling Tang · 2025 · Pharmaceuticals
7. How predictive are isolated perfused liver data of in vivo hepatic clearance? A meta-analysis of isolated perfused rat liver data
   J Schulz, J. Cory Kalvass · 2024 · Xenobiotica
8. Cytochrome P450-mediated metabolic interactions between donepezil and tadalafil in human liver microsomes
   Jieun Yu, Ji Hyeon Ryu, Yong Ha Chi, Soo Heui Paik, Sang Kyum Kim · 2024 · Toxicology in Vitro
9. Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis
   Allan Kengo, Firdaus Nabeemeeah, P. Denti, Ryan Sabet, Gifty Okyere-Manu, P. Abraham, Lubbe Weisner, M. Mosala, Sibongile Tshabalala, J. Scholefield et al. · 2024 · Antimicrobial Agents and Chemotherapy
10. Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery
    Mitesh Patel, Julia Riede, Dallas Bednarczyk, Birk Poller, Sujal V. Deshmukh · 2023 · Pharmaceutical Research
11. Species differences in metabolism of a new antiepileptic drug candidate, DSP‐0565 [2‐(2′‐fluoro[1,1′‐biphenyl]‐2‐yl)acetamide]
    M. Yahata, Yuji Ishii, T. Nakagawa, Takao Watanabe, K. Bando · 2019 · Biopharmaceutics & drug disposition
12. Gender differences in the hepatic elimination and pharmacokinetics of lobeglitazone in rats.
    Jong-Hwa Lee, Jun-Hyeng Son, Y. Chae, Sung-Hoon Ahn, Wooin Lee, Dae-Duk Kim, S. Chung · 2015 · Biopharmaceutics & drug disposition
13. Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics
    Joo H. Lee, Young-Joo Lee, E. Oh · 2014 · The Journal of pharmacy and pharmacology
14. Quantitative Biochemistry in the Pharmacological Evaluation of Drugs
    R. Copeland · 2013
15. Physiologically Based Pharmacokinetic ( PBPK ) Modeling: Usefulness and Applications
    Han‐Joo Maeng, Edwin C.Y. Chow, Jianghong Fan, K. Sandy Pang · 2012 · Encyclopedia of Drug Metabolism and Interactions
16. Mechanistic modeling of drug elimination by the liver using local volume averaging method
    M. Izadifar, O. Baik, J. Alcorn · 2011 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society
17. Method for evaluating metabolic functions of drugs in bioartificial liver
    Yueng Guen Park, Hiroo Iwata, Seiji Satoh, Takehiko Uesugi, Hwa‐Won Ryu · 2003 · Biotechnology and Bioprocess Engineering
18. Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment
    P. Rocha, M. Guerret, D. David, X. Marchand, J. Kahn · 1990 · Cardiovascular Drugs and Therapy
19. Statistical moments and disposition parameters in a local perfusion system under mammillary nonequilibrium condition
    T. Kakutani, E. Nara, M. Hashida · 1990 · Journal of pharmacokinetics and biopharmaceutics
20. How Science Is Driving Regulatory Guidances.
    Xin-Ning Yang, Jiang-Hong Fan, Lei Zhang · 2021 · Methods in molecular biology
21. Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.
    U. Lee, E. Oh · 2015 · Biopharmaceutics & drug disposition
22. Bayesian Inference in Physiologically-based Pharmacokinetic Modeling: Application to Aniticancer Drug Development
    Lu Xu, D. D'Argenio, J. Eiseman, M. Egorin · 2004
23. Applicability of next-generation risk assessment generic PBK models and their performance within the chemical domain
    M. Spaenig, M. Ashraf, M. Bouhifd, C. Drake, T. Sobanski, S. E. Escher · 2026 · Archives of Toxicology
24. In vitro hepatic clearance of enniatin B1: interspecies and cell model comparison
    Mariam Mahdjoub, Estelle Dubreil, C. Gendre, Ludovic Le Hégarat, Jérôme Henri · 2026 · Archives of Toxicology
25. Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
    A. L. Ravi Shankar, Jenny Irwan, M. Spaenig, Maxim P. Carlier, T. Hansen, Nicole Zumbülte, Barira Islam, Patrik Lundquist, Richard Svensson, Todd Gouin et al. · 2026 · Archives of Toxicology
26. Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib
    Joanneke K. Overbeek, Nielka P. van Erp, David Marinus Burger, Alfons A den Broeder, Stijn L.W. Koolen, Alwin D. R. Huitema, Rob ter Heine · 2025 · Clinical Pharmacokinetics
27. A commentary on “Are all measures of liver Kpuu a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?”
    Kiyohiko Sugano · 2024 · European Journal of Pharmaceutical Sciences
28. A tutorial for model‐based evaluation and translation of cardiovascular safety in preclinical trials
    Victoria Kulesh, Igor Vasyutin, Alina Volkova, Kirill V. Peskov, Holly H. C. Kimko, Victor Sokolov, Ravindra V. Alluri · 2023 · CPT Pharmacometrics & Systems Pharmacology
29. Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate
    Xiangyu Chen, Guo Yu, Guo-Fu Li · 2023 · European journal of drug metabolism and pharmacokinetics
30. Elimination Clearance of Dexmedetomidine: Cross-examining What the Data Say.
    T. Henthorn, T. Krejcie, M. Avram · 2021 · Anesthesiology
31. In-silico virtual prototyping multilevel modeling system for Cyborgs (CybSim) as a novel approach for current challenges in biosciencies
    M. Prado-Velasco · 2021 · Proceedings of 14th Modelica Conference 2021, Linköping, Sweden, September 20-24, 2021
32. Noteworthy idiosyncrasies of 1α,25‐dihydroxyvitamin D3 kinetics for extrapolation from mouse to man: Commentary
    Keumhan Noh, Qi Joy Yang, Lavtej Sekhon, Holly P. Quach, Edwin C.Y. Chow, K. Sandy Pang · 2020 · Biopharmaceutics & Drug Disposition
33. PBPK Modeling and In Silico Prediction for ADME and Drug–Drug Interaction
    Souzan B. Yanni · 2015
34. MASS TRANSFER MODELING OF HEPATIC DRUG ELIMINATION USING LOCAL VOLUME AVERAGING APPROACH
    M. Izadifar, J. Alcorn · 2012
35. Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice
    M. Bader, J. Baumann, S. Figueroa, Chris Laux, M. Guanci, Claranne Mathiesen, S. Livesay · 2012 · Therapeutic Hypothermia and Temperature Management
36. In Vitro–In Vivo Correlations of Hepatic Drug Clearance
    R. Obach · 2012
37. Evaluation of the pharmacokinetics and metabolism of a novel histone deacetylase inhibitor, KBH-A40, in rats
    S. Oh, K. Lee, J. Ryu, H.-E. Yu, G. Han, S. Park, J. S. Kang, H. Kim, Y. C. Kim · 2011 · Xenobiotica; the fate of foreign compounds in biological systems
38. Estimation of Human Starting Dose for Phase I Clinical Programs
    Lorrene A. Buckley, Parag Garhyan, Rafael A. Ponce, Stanley Roberts · 2010 · Wiley eBooks
39. Enantiomer-enantiomer interaction of a calcium channel antagonist, benidipine hydrochloride, during liver metabolism in the rat
    H. Kobayashi, S. Kobayashi · 1999 · European journal of drug metabolism and pharmacokinetics
40. Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration
    S. Akrawi, P. Wedlund · 1989 · European journal of drug metabolism and pharmacokinetics
41. Stable Oral Availability of Atenolol Coadministered with Hydralazine
    A. Mclean, D. Wilhelm, B. Heinzow · 1983 · Drugs
42. PBPK Modeling to Estimate Metabolite Formation From First-Pass Organs: Intestine and Liver
    Qi Joy Yang, K. Sandy Pang · 2017 · Elsevier eBooks
43. Prediction of human systemic, biologically relevant pharmacokinetic (PK) properties using quantitative structure pharmacokinetic relationships (QSPKR) and interspecies pharmacokinetic allometric scaling (PK-AS) approaches for four different pharmacological classes of compounds
    Gopichand Gottipati · 2014
44. Recent Developments in Physiologically Based Pharmacokinetic Modeling
    Vikash Sinha, Holly H. C. Kimko · 2010 · AAPS advances in the pharmaceutical sciences series
45. Dynamische Modellierung und Simulation des Arzneimittelmetabolismus in humanen Leberzellen: Identifizierbarkeit, Robustheit und inter-individuelle Variabilität
    J. Bucher · 2011
46. Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina
    K. Boje, H.-L. Fung, K. Yoshitomi, J. O. Parker · 2004 · European Journal of Clinical Pharmacology
47. Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats
    Tae‐Heon Kim, Jong‐Woo Jeong, Ji‐Hye Song, Kyeong‐Ryoon Lee, Sunjoo Ahn, Sung‐Hoon Ahn, Sungsub Kim, Tae‐Sung Koo · 2015 · Archives of Pharmacal Research
48. Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats
    Zhi-Xia Zheng, Hyewon Seo, Hyun-Jung Kwak, K. Kim, J. Ahn, M. Bae, J. Song · 2016 · Archives of pharmacal research
49. In Vitro-In Vivo Extrapolation of Hepatic Clearance for GalNAc-siRNA Therapeutics Using Rat Liver Tritosomes
    Harvey Andersen, Alec Bell, Ryan Hill, Anthony Murphy, Michael Huskin, M. Mohutsky, Christopher M. Wiethoff · 2026 · Drug Metabolism And Disposition
50. Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism
    Hiroshi Arakawa, Dai Shengyu, Yukio Kato · 2026 · Biochemical Pharmacology
51. Development of Integrated Parent–Metabolite Pharmacokinetic Model With Apparent Presystemic Metabolism to Characterize the Disposition of Alverine
    Ara Cho, Hyeon-Cheol Jeong, MinJu Kim, Inkyung Cho, Hyeon‐Jeong Na, Kyong‐Cheol Ko, Yoon‐Jee Chae, Kyeong‐Ryoon Lee · 2026 · CPT Pharmacometrics & Systems Pharmacology
52. A single bioanalytical LC-MS/MS method for the quantification of pelitinib across biological matrices: An insight into in vitro metabolic stability, in vivo pharmacokinetics, and IVIVE.
    H. Bhalerao, Pooja Dhurjad, Anish Bharate, R. Sonti · 2026 · Journal of Pharmaceutical and Biomedical Analysis
53. Drugs and the liver
    Andrew T. Lambarth, Christopher JD Threapleton · 2026 · Anaesthesia & intensive care medicine
54. Finding the dispersion number (DN) of the dispersion model from perfused rat and human liver studies.
    K. Pang, R. Tirona, Betty P. Li, A. Schwab · 2026 · Drug Metabolism And Disposition
55. Deconvoluting the in vitro to in vivo drug clearance gap: Questioning the predictive performance of traditional hepatic clearance models
    Sofie Heylen, Johan Nicolaï, Stijn Van Asten, Katie De Wagter, Andrea Treyer, Jan Snoeys, Raymond Evers, Stephanie Kourula, Pieter Annaert · 2026 · European Journal of Pharmaceutical Sciences
56. Characterization of small molecule drug clearance mechanisms using in vitro and in vivo approaches in drug discovery and development
    Cindy Yanfei Li, Nashid Farhan, Erickson Mesina Paragas, Hiranmayee Kandala, Upendra P. Dahal · 2025 · Expert Opinion on Drug Metabolism & Toxicology
57. A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone
    Shamia L. Faison, J. Batonga, T. Arumugham, Angela Bartkus, Marion Morrison, Mark Mullin, Tim Tippin, O. Naderer · 2025 · Journal of clinical pharmacology
58. Pharmacokinetics of carprofen in Siamese crocodiles (Crocodylus siamensis).
    Seavchou Laut, S. Poapolathep, N. Klangkaew, N. Phaochoosak, T. Wongwaipairoj, Elena Badillo, P. Marín, Elisa Escudero, M. Giorgi, A. Poapolathep · 2025 · Research in Veterinary Science
59. In vitro and in vivo evaluation of propylene glycol ethers metabolism in humans.
    Hélène P. De Luca, Myriam Borgatta, Sophie Werner, Pascal Wild, S. Le Gludic, Laura Suter-Dick, N. Hopf · 2025 · Environmental Toxicology and Pharmacology
60. Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach
    Juyoung Khwarg, Eunsol Yang, Chan Song Park, Sang-Chun Ji, Kyung-Sang Yu, Seunghwan Lee · 2024 · Clinical and Translational Science
61. Assessment of the Kochak-Benet Equation for Hepatic Clearance for the Parallel-Tube Model: A Response to Jusko and Li.
    G. Kochak · 2022 · Journal of Pharmacy and Science
62. Preliminary Flow Modeling by Hybrid Automata Alternating Continuous Reaction and Discrete Transit for Pharmacokinetics
    S. Koyama · 2021 · Drug Metabolism And Disposition
63. Extended Clearance Classification System ( ECCS ) and its Utility in Predicting Clearance Rate‐Determining Step in Drug Discovery
    Ayman F. El‐Kattan · 2017 · Wiley eBooks
64. Response to Letter to the Editor on “Fractional Clearance for Verapamil N-Demethylation in the Isolated Rat Liver Preparation”
    K. Pang, Q. Yang · 2015 · Drug Metabolism And Disposition
65. Effects of physiological and biochemical factors based on aging, pathological conditions and drug combinations on propranolol pharmacokinetics using physiologically-based pharmacokinetic model in humans
    A. Kiriyama, Akino Honbo, K. Iga · 2013
66. Bioactivation and Inactivation of Cytochrome P450 and Other Drug‐Metabolizing Enzymes
    A. Kalgutkar, D. Dalvie, R. Obach, Dennis A. Smith · 2012
67. Pharmacodynamic response to warfarin after conversion of atrial fibrillation or flutter to sinus rhythm.
    M. Staats, Michael E. Ernst · 2012 · American Journal of Health-System Pharmacy
68. Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice
    Sarah L. Livesay, Stephen A. Figueroa, Leslie A. Hamilton, William D. Cahoon, Patricia A. Blissitt · 2017 · Therapeutic Hypothermia and Temperature Management
69. Principles of Pharmacokinetics: Predicting Human Pharmacokinetics in Drug Discovery
    Takehito Yamamoto, Hiroshi Suzuki, Akihiro Hisaka · 2011
70. Editorial
    Leon J Aarons, Leslie Z. Benet · 2010 · Journal of Pharmacokinetics and Pharmacodynamics
71. Prediction of Pharmacokinetics and Drug Safety in Humans
    Peter L. Bullock · 2010 · Wiley eBooks
72. Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio
    Martin van der Graaff, Nico P.E. Vermeulen, Douwe D. Breimer · 1986 · Pharmacy World & Science
73. The use of marker drugs to measure organ function: A theoretical interpretation
    John Cobby, M. Makoid · 1980 · European Journal of Clinical Pharmacology
74. Holistic Assessment of Compound Properties—In Vitro to In Vivo Pharmacology
    Andrew Baxter · 2021 · Elsevier eBooks
75. Mathematical Aspects of Clinical Pharmacokinetics
    R. Tirona · 2021
76. Quantitative Analysis of Intracellular Drug Concentrations in Hepatocytes
    Chitra Saran, James J. Beaudoin, Nathan D. Pfeifer, Kim L. R. Brouwer · 2021 · Methods in pharmacology and toxicology
77. Characterization of drug disposition in humans using novel in vitro methodologies based on the Extended Clearance Model
    Julia Riede · 2017
78. Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic
    Bianca M. Liederer, Xingrong Liu, Simon G.W. Wong, Daniel R. Mudra · 2017 · AAPS advances in the pharmaceutical sciences series
79. A pharmacokinetic receptor-based recirculation model for target-mediated disposition drugs
    Mohammed H. Elkomy · 2012
80. Physiological Modeling of the Small Intestine in Drug Absorption
    K. Pang · 2004